STAT - Reporting from the frontiers of health and medicine

Skip to Main Content

Explore what it takes to make the health care system work.

Explore what it takes to make the health care system work.

March 22, 2024

Pregnancy increases biological age — but recovery and breastfeeding can undo the damage, study finds
March 22, 2024

FDA authorizes new drug to protect immune compromised from Covid-19
March 22, 2024

How a for-profit health system’s push to expand ended in disappointment for a tiny island nation
March 22, 2024

Up and down the ladder: The latest comings and goings
March 22, 2024

Pharmalittle: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more
March 22, 2024

EU adviser says Illumina merger was not problematic

Join fellow industry leaders in NYC this March for Breakthrough Summit East

Learn more

STAT Plus: Hospitals turn to sports performance centers to offer athletes elite care — for the right price

Hospitals tap into a growing market by moving beyond sports medicine to sports performance, using pro league ties and a self-pay model.

Health March 22, 2024

Abortion law emergency-exemption guidance proposed by Texas Medical Board

Health March 22, 2024

STAT Plus: Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles

Biotech March 22, 2024

STAT Plus: How biotech investors spot opportunity when stocks are down — and up

STAT Madness March 22, 2024

Male birth control research wins audience over at STAT Madness event

Sponsored

Advertisement

All First Opinion

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer

Gene-edited pig kidney transplanted into a living patient for the first time

Medicare expected to negotiate obesity drug prices soon, new analysis predicts

Prometheus team launches new startup with $400 million to tackle immune-driven disorders

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

STAT in DC: Policy in Health Care

Washington, DC April 29, 2024

Join STAT’s DC bureau alongside policymakers, advocates, & industry experts to discuss the biggest policy issues shaping health care.

16

May

2024 STAT Breakthrough Summit West

San Francisco, CA

29

Mar

Championing the Patient Voice

Virtual

03

Apr

GLP-1s: Distilling Signal from Noise

Virtual

All Events

More Stories

Health March 22, 2024

Pregnancy increases biological age — but recovery and breastfeeding can undo the damage, study finds

Biotech March 22, 2024

FDA authorizes new drug to protect immune compromised from Covid-19

Hospitals March 22, 2024

STAT Plus: How a for-profit health system’s push to expand ended in disappointment for a tiny island nation

Pharmalot March 22, 2024

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot March 22, 2024

STAT Plus: Pharmalittle: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more

The Readout March 22, 2024

EU adviser says Illumina merger was not problematic

Biotech March 22, 2024

STAT Plus: Drug development was once a marathon. New tools and timelines are turning it into a sprint

Opinions+ March 22, 2024

STAT Plus: Medical devices makers are trying to take a page from Uber’s playbook

The Readout LOUD March 21, 2024

Live! From the STAT Breakthrough Summit East

Health March 21, 2024

Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’

Health March 21, 2024

STAT Plus: Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher

Biotech March 21, 2024

STAT Plus: Regeneron’s plot to ‘cure’ allergies

Biotech March 21, 2024

STAT Plus: Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Health tech March 21, 2024

STAT Plus: Digital tools for diabetes management did not deliver benefits that justify cost, new report finds

Biotech March 21, 2024

STAT Plus: Gene-edited pig kidney transplanted into a living patient for the first time

Pharmalot March 21, 2024

STAT Plus: Pharmalittle: We’re reading about Medicare and obesity drugs, GSK asthma inhalers, and more

Biotech March 21, 2024

STAT Plus: Prometheus team launches new startup with $400 million to tackle immune-driven disorders

Pharmalot March 21, 2024

STAT Plus: Pharma companies and their allies seek to exempt orphan drugs from state pricing limits

Opinions+ March 22, 2024

STAT Plus: Medical devices makers are trying to take a page from Uber’s playbook

Adam's Take March 21, 2024

STAT Plus: A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

Matt's Take March 19, 2024

A study says intermittent fasting is making people drop dead. Oh, come on

Adam's Take March 18, 2024

STAT Plus: I was wrong about Geron’s blood cancer drug. Now, is it a takeover target?

Off the Charts March 18, 2024

The harms of adverse childhood experiences are well-known. But positive experiences can affect future health, too

First Opinion March 15, 2024

Lessons for scientists from the All of Us Research Program backlash

Newsletters

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Vote now in STAT Madness 2024

By STAT Staff

Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction

STAT Plus: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?

How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic

Amid the battle over abortion rights, a failure to agree on how to define abortion

By Saima May Sidik

STAT Plus: UnitedHealth is on a buying spree of outpatient surgery centers

Girls are starting puberty earlier than ever. For some, that comes with major mental health risks

Introducing the 2024 STATUS List, the definitive accounting of leaders in the life sciences

By STAT Staff

STAT Plus: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

Biotech March 20, 2024

STAT Plus: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

Biotech March 18, 2024

STAT Plus: FDA approves first gene therapy for fatal neuron disease in children

Biotech March 16, 2024

STAT Plus: The Boston area built a ton of lab space. Now many of those buildings are opening empty

STAT Plus: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more

Pharmalot March 20, 2024

STAT Plus: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more

Pharmalot March 19, 2024

STAT Plus: Pharmalittle: We’re reading about an AstraZeneca deal, a WHO pandemic pact, and more

Pharma March 19, 2024

STAT Plus: As targeted radiation field heats up, AstraZeneca to acquire Fusion Pharmaceuticals in $2 billion deal

Overdose deaths hit another record but show signs of leveling off

Health March 21, 2024

Overdose deaths hit another record but show signs of leveling off

Health March 20, 2024

The U.S. banned asbestos, but its health impact will still be felt for decades

Health March 19, 2024

STAT Plus: In small study, baby aspirin cuts fat buildup in liver disease patients

Fetal tissue research gains in importance as roadblocks multiply

Politics March 20, 2024

Fetal tissue research gains in importance as roadblocks multiply

Politics March 18, 2024

Supreme Court questions restricting government efforts to limit Covid-19 misinformation

Politics March 14, 2024

STAT Plus: Senators press HHS secretary on Change HealthCare cyberattack fallout

Video

Watch: Why fentanyl withdrawal is agony and how medication can prevent it

What is in utero gene editing?

Treating Rural America: The telehealth solution

A conversation with the 2023 STAT Wunderkinds

War on Recovery

War on Recovery

STAT Plus: As AI marches into medicine, investors eye security, privacy startups

Health tech March 18, 2024

STAT Plus: As AI marches into medicine, investors eye security, privacy startups

Health tech March 14, 2024

STAT Plus: EPA restricts cancer-causing chemical used to sterilize medical devices

Health tech March 14, 2024

STAT Plus: Q&A: Amid AI frenzy in medicine, a federal regulator’s quest to create safeguards

STAT Plus: U.K. health officials and researchers try to carve a path for more individualized genetic treatments

In the Lab March 21, 2024

STAT Plus: U.K. health officials and researchers try to carve a path for more individualized genetic treatments

In the Lab March 20, 2024

STAT Plus: A scientific mystery highlights the blind spots in genomics databases

In the Lab March 15, 2024

Q&A: Is it time for scientists to rethink how they study sex in research?

STAT Plus: Hospitals struggle to validate AI-generated clinical summaries. ‘It’s a bit chaotic’

Hospitals March 13, 2024

STAT Plus: Hospitals struggle to validate AI-generated clinical summaries. ‘It’s a bit chaotic’

Hospitals March 12, 2024

STAT Plus: For-profit health system’s Mass. hospitals teetering on the brink of financial disaster

Hospitals March 1, 2024

STAT Plus: RaDonda Vaught, nurse who accidentally killed patient, to speak at CommonSpirit event on patient safety

STAT Plus: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open

Insurance March 14, 2024

STAT Plus: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open

Insurance March 5, 2024

STAT Plus: Large insurers say up to one-quarter of claims run through Change Healthcare

Insurance March 4, 2024

STAT Plus: Explaining Change Healthcare and the gravity of its cyberattack

Podcasts

Live! From the STAT Breakthrough Summit East

A dilemma in ALS, the first MASH drug, & why gene therapy is hard

VC turmoil, GLP-1 competition, & the war on recovery

Legal insider trading, booming biotech stocks, & the next GLP-1